Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00986362 · ClinicalTrials.gov registry record · Phase 2
Clinical Trial of Intravitreal Microplasmin in Infants and Children Scheduled for Vitrectomy
A Phase 2 study, sponsored by ThromboGenics.
- Completed
- Registry status
- Phase 2
- Development phase
- 24
- Enrollment target
NCT00986362: Completed Phase 2 study, sponsored by ThromboGenics.
NCT00986362 is a Phase 2 study that has completed, run by ThromboGenics. The registered enrollment target is 24 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00986362, a Phase 2 study, has completed, sponsored by ThromboGenics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 24 participants
- Enrollment target
Study Summary
To evaluate the safety and preliminary efficacy of intravitreal microplasmin as an adjunct to conventional vitrectomy for the treatment of pediatric patients.
Primary Outcome
Percentage of eyes with total macular PVD (to the vascular ridge in eyes with ROP) at the beginning of vitrectomy or after application of suction, as assessed by masked surgeon observation under the operating microscope.
Interventions
- DRUG Placebo
- DRUG Ocriplasmin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2010-02 |
| Est. Completion | 2012-04 |
| Phase | Phase 2 |
What the finished NCT00986362 record still lists
NCT00986362 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00986362 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00986362 about?
NCT00986362 is a clinical study titled "Clinical Trial of Intravitreal Microplasmin in Infants and Children Scheduled for Vitrectomy". To evaluate the safety and preliminary efficacy of intravitreal microplasmin as an adjunct to conventional vitrectomy for the treatment of pediatric patients.
What is the current status of trial NCT00986362?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 24 participants. The study started on 2010-02. Estimated completion is 2012-04.
What interventions are being tested in trial NCT00986362?
The interventions under investigation include: Placebo (DRUG), Ocriplasmin (DRUG).
Who is sponsoring clinical trial NCT00986362?
This trial is sponsored by ThromboGenics, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00986362's enrollment target sits among peer trials
24 1756th of 2000 higher than 217 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia